Patent ID: 11959925
Assignee: THE JACKSON LABORATORY
Field: Measurement (Instruments)
Classification: CPC G  A  C | IPC A  C  G

Claim 10:
11. The method of claim 1, wherein the immunomodulatory agent is selected from granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod, thalidomide and its derivatives or analogues, lenalidomide, pomalidomide, apremilast, azathioprine, cladribine, cyclophosphamide, intravenous immunoglobulin, methotrexate, mitoxantrone, talimogene laherparepvec, a genetically modified oncolytic viral therapy, daratumumab, an antiCD38 antibody, adalimumab, elotuzumab, epacadostat, an orally available hydroxyamidine inhibitor of indoleamine 2,3-dioxygenase (ID01), catumaxomab, ibritumomab tiuxetan, tositumomab-I131, brentuximab vedotin, betuximab, rituximab, alemtuzumab, bevacizumab, pertuzumab, trastuzumab, trastuzumab emtansinen, denosumab, ipilimumab, ofatumumab, and panitumumab.